Bruker Announces Formation of New Bruker Spatial Biology Division
Bruker Spatial Biology Offers the Widest Range of Industry-leading Multiomic Spatial Biology Platforms to Scientists Globally
BILLERICA, Massachusetts, October 9, 2024 -- (BUSINESS WIRE) – Bruker Corporation (Nasdaq: BRKR) today announced the formation of a new division, Bruker Spatial Biology, offering the most diverse and comprehensive solutions for spatial biology. Bruker Spatial Biology brings together in operational coordination three entities: the two businesses of NanoString Technologies and Canopy Biosciences, along with its subsidiary Bruker Spatial Genomics, Inc. (formerly known as Acuity Spatial Genomics, Inc.).
Bruker Spatial Biology will focus on elevating the industry’s most promising technologies for the advancement of biomedical research with a suite of spatial biology instruments, assays, software, data analytics, and CRO services. This uniquely positions Bruker’s new division with a comprehensive and cutting-edge spatial technology offering that includes NanoString’s GeoMx®, CosMx™, and AtoMx™ platforms along with Canopy Biosciences’ CellScape™system, all specifically designed to address distinct spatial biology research needs. NanoString’s nCounter® Analysis System is also included in the portfolio along with Canopy’s Multi-Omic Services, which provides contract research services utilizing each of these platforms.